Platelets, endothelium-dependent responses and atherosclerosis.
Basal release of endothelium-derived relaxing factor (EDRF) and prostacyclin from intact vascular endothelium may inhibit continuously platelet aggregation. If local platelet aggregation occurs, platelet-derived adenine nucleotides stimulate the release of EDRF. Stimulated EDRF release may override the direct vasoconstrictor effects of other platelet products such as thromboxane and serotonin resulting in local vasodilatation. In addition, stimulation of EDRF release by adenine nucleotides may inhibit further platelet adhesion and aggregation by a feedback mechanism. Thus, intact vascular endothelium may play an important role in the defense against platelet deposition and vasospasm. In atherosclerosis, basal and stimulated release of EDRF is markedly reduced. Endothelial dysfunction will impair this protective mechanism and will favour vasoconstriction and further platelet disposition. Occurrence of occlusive thrombus formation in patients with coronary artery disease may be pathophysiologically related to this impairment of endothelial defense.
Mügge
A
A
Division of Cardiology, Hannover Medical School, Germany.
Förstermann
U
U
Lichtlen
P R
PR
D000818:Animals; D001161:Arteriosclerosis / Q000209:etiology*; D004730:Endothelium, Vascular / Q000502:physiology*; D006801:Humans; D009569:Nitric Oxide / Q000502:physiology*; D010974:Platelet Aggregation / Q000502:physiology*; D014661:Vasoconstriction / Q000502:physiology; D014664:Vasodilation / Q000502:physiology
D009569:Nitric Oxide